1 / 84

Anesthesia for Cesarean Section

Anesthesia for Cesarean Section. Michelle Gros, FRCPC Feb 13, 2008. Cesarean Section. Cesarean section rate in Canada in 2005 was 23.7% (CIH) Cesarean section rate in US now exceeds 24% Incidence of anesthesia-related maternal mortality is declining

dagan
Télécharger la présentation

Anesthesia for Cesarean Section

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anesthesia for Cesarean Section Michelle Gros, FRCPC Feb 13, 2008

  2. Cesarean Section • Cesarean section rate in Canada in 2005 was 23.7% (CIH) • Cesarean section rate in US now exceeds 24% • Incidence of anesthesia-related maternal mortality is declining • Anesthesia remains responsible for ~ 3-12% of all maternal deaths • Majority during general anesthesia (failed intubation, failed ventilation and oxygenation, and or aspiration) • Associated factors include obesity, hypertensive disorders of pregnancy, and emergently performed procedures

  3. Cesarean Section • Review of anesthetic technique used for all c-sections performed at Brigham and Women’s hospital between 1990 and 1995 • GA  from 7.2% in 1990 to 3.6% in 1995 • Are we getting enough experience in GA’s for c-sections?

  4. Preparation for Anesthesia - Meds • Minimize drugs prior to delivery of infant • If necessary, midazolam 0.5 – 1 mg or fentanyl 25-50 ug IV • Small doses – minimal fetal and neonatal depression • Disadvantage of benzos – ? • Anticholinergics – decreases secretions • Atropine – crosses placenta -  FHR and  variability • Glycopyrrolate – does not cross placenta • Aspiration prophylaxis

  5. Preparation for Anesthesia - Meds • CJA 2006; 53(1): 79-85. • RCT of 60 women • Either 1 ug/kg fent and 0.02 mg/kg midaz IV, OR an equal volume IV NS at time of skin prep for spinal • No between group differences of neonatal outcome variables (Apgar, neurobehavioural scores, continuous oxygen saturation) • Mothers had no difference in recall of the birth

  6. Preparation for Anesthesia – IV Fluids • Prior to regional – 15-20 mL/kg RL or NS • 30 mins prior • Rout et al. 1993 – incidence of hypotension  from 71% to 55% if prehydrated • Message: • Additional means are necessary • In urgent situation – not necessary to wait for fluid bolus •  hypotension – means improved uteroplacental perfusion • ?crystalloid vs. colloid

  7. Preparation for Anesthesia – IV Fluids • CJA 2000; 47: 607-610. • Crystalloid preload no longer magic bullet • Study found 1 L crystalloid preload was of no value in preventing hypotension • Both speed and volume of preloading unimportant • Still reasonable to give modest preload prior to spinal • Patients are often relatively dehydrated • BUT – no need to delay emergency surgery in order to preload

  8. Preparation for Anesthesia – IV Fluids • Siddik showed 500 mL pentaspan more effective than 1 L NS in reducing hypotension (40% vs. 80%) • N+V also reduced in colloid group • Neonatal outcome unaffected • Riley et al showed less hypotension in colloid group (45% vs. 85%) but no difference in nausea scores or neonatal outcome

  9. Preparation for Anesthesia – IV Fluids • French et al showed less hypotension in colloid group (12.5% vs. 47.5%), again no differences in neonatal outcome • Karinen et al failed to find any differences in hypotension when colloid was used

  10. Preparation for Anesthesia – IV Fluids • Disadvantages to Colloid? • Expensive • Anaphylactoid reactions • Coagulation effects

  11. Preparation for Anesthesia – IV Fluids • Is type, amount, timing of fluids that important? • Also consider: • Effective LUD - 15 often not enough • Aggressive use of vasopressors • Low dose spinal anesthesia

  12. Preparation for Anesthesia – Maternal Position • Avoid aortocaval compression • Results in  uteroplacental perfusion by 3 mechanisms: •  venous return   C.O. and BP • Obstruction of uterine venous drainage ’s uterine venous pressure and  uterine artery perfusion pressure • Compression of aorta or common iliac arteries   uterine artery perfusion pressure

  13. Preparation for Anesthesia – Monitors • Standard monitors • +/- art, CVP • FHR • Before, during, after administration of anesthesia • Evaluates effects of maternal position, anesthesia, hypotension, and other drugs on the fetus

  14. General Considerations • ? Support person • ? Oxygen

  15. General Considerations - Oxygen • For elective c-section, current evidence suggests that supplementary oxygen is unnecessary • For emergency section – further data are required • Improvement of fetal oxygenation should be primary objective – this achieved in short-term by using very high FiO2 • BUT, possibility of reperfusion injury with free radicals

  16. Prevention of Maternal Complications - Aspiration • ALL patients should receive aspiration prophylaxis, regardless of planned anesthetic for c-section • Large survey from Sweden • Incidence of aspiration ~ 15 per 10,000 cases of GA for c-sxn • 3X greater than in nonobstetric surgery

  17. Preventing Aspiration – Pharmacologic Tx • Non-particulate antacid eg. 0.3 M sodium citrate • H2-receptor antagonist •  gastric pH, BUT does NOT alter pH of existing gastric contents • Rout et al 1993– IV ranitidine 50 mg + po Na citrate  resulted in greater  in gastric pH than Na citrate alone (provided >30 mins from time of administration to intubation)

  18. Preventing Aspiration – Pharmacologic Tx • Proton pump inhibitor eg. losec •  gastric acidity • One study found it less effective than ranitidine • Metoclopramide • Accelerates gastric emptying • ? Reliability of emptying stomach before c-sxn •  lower esophageal sphincter tone • Antiemetic effect

  19. Prevention of Maternal Complications - Hypotension • In obstetric patients -  in SBP > 25% OR, any SBP < 100 mmHg • Measures of prevention: • Fluids • LUD • Prophylactic vasopressors (ephedrine, phenylephrine)

  20. Prevention of Maternal Complications - Hypotension • Lee et al., CJA 2002 – systematic review of RCT’s of ephedrine vs. phenylephrine for tx of hypotension during spinal for c-sxn • No difference for prevention and treatment of maternal hypotension • Maternal bradycardia more likely to occur with phenylephrine than with ephedrine • No difference in the incidence of fetal acidosis (umbilical artery pH < 7.2)

  21. Prevention of Maternal Complications - Hypotension • Chestnut says: • They still mostly use ephedrine • Phenylephrine preferred in patients who may not tolerate tachycardia eg. MS

  22. Prevention of Maternal Complications - Hypotension • Varying reports of efficacy of prophylactic ephedrine • Some advocate 25 – 50 mg IM before spinal, or 5-10 mg IV immediately after intrathecal injection • Chestnut – don’t give prophylactic ephedrine unless pt has a low baseline BP (ie. SBP <105 mmHg before spinal)

  23. Prevention of Maternal Complications - Failures • Failed spinal • ~ 1% of cases

  24. Prevention of Maternal Complications - Failures • Failed spinal • ~ 1% of cases • If delivery not urgent – 2nd spinal

  25. Prevention of Maternal Complications - Failures • Failed spinal • ~ 1% of cases • If delivery not urgent – 2nd spinal • Failed epidural • ~ 2-6% of cases

  26. Prevention of Maternal Complications - Failures • Failed spinal • ~ 1% of cases • If delivery not urgent – 2nd spinal • Failed epidural • ~ 2-6% of cases • Repeat epidural • Watch for local toxicity • Pt impatient

  27. Prevention of Maternal Complications - Failures • Failed spinal • ~ 1% of cases • If delivery not urgent – 2nd spinal • Failed epidural • ~ 2-6% of cases • Repeat epidural • Watch for local toxicity • Pt impatient • Spinal • Collection of local – falsely think this is CSF • High spinal

  28. Prevention of Maternal Complications - Failures • Chestnut: • ~ 5% planned epidurals converted to spinals • High spinals in 3 of 27 (11%)

  29. Repeat Scheduled Failed attempt at vaginal delivery Dystocia Abnormal presentation Transverse lie Breech Multiple gestation Fetal stress/distress Deteriorating maternal medical illness Preeclampsia Heart disease Pulmonary disease Hemorrhage Placenta previa Placental abruption Indications for Cesarean Section

  30. Choice of Technique

  31. Choice of Technique • Indication for c-sxn • Urgency of procedure • Health of mother and fetus • Desires of mother

  32. Spinal Pros: • Simple • Rapid onset • Dense blockade • Negligible maternal risk of systemic local toxicity • Minimal transfer of drug to infant • Negligible risk of local anesthetic depression of infant

  33. Spinal Cons: • Rapid onset of sympathetic blockade – abrupt, severe hypotension • Limited duration • Recovery time may be prolonged (if procedure shorter than anticipated)

  34. Epidural • Popularity increasing • LA  nerve roots (dural cuffs) by absorption through arachnoid villi that penetrate dura •  spread of anesthesia is volume dependent

  35. Epidural Pros: • Titrated dosing and slower onset   risk of severe hypotension and reduced uteroplacental perfusion • Duration of surgery not an issue • Less intense motor blockade  good for pts with multiple gestation or pulmonary disease • Lower extremity “muscle pump” may remain intact  may  incidence of thromboembolic disease

  36. Epidural Cons: • Slower onset • Risk of systemic local toxicity • Greater placental transfer of drug than with spinal • BUT – does not affect neonatal neurobehaviour and of little clinical significance when appropriate doses used • Risk of high spinal

  37. Combined Spinal – Epidural (CSE) • Initially described in 1981 (epidural catheter at L1-2 and spinal at L3-4)

  38. Combined Spinal – Epidural (CSE) Pros: • Rapid onset and density of spinal anesthesia combined with versatility of epidural anesthesia Cons: • Potential for high spinal • Inability to test epidural catheter • Only 1 published report of presumed unintentional insertion of epidural catheter through dural puncture site

  39. Spinal Anesthesia for C - Section • Metoclopramide 10 mg IV • Clear antacid orally • Intravascular volume expansion with RL or NS (15-20 mL/kg) • Application of monitors • Supplemental oxygen by face mask or nasal prongs • Prophylactic intramuscular ephedrine (25-50 mg) in patients with a baseline SBP < 105 mmHg

  40. Spinal Anesthesia for C - Section • Lumbar puncture at L3-4 • Right lateral or sitting position • 25-gauge Sprotte or Whitacre needle • Bupivacaine 12 mg (heavy) • Morphine 0.1-0.25 mg for postoperative analgesia • Left uterine displacement • Aggressive treatment of hypotension • Exaggerated LUD • IV fluids • Ephedrine and/or low dose phenylephrine

  41. Drugs Used for Spinal Anesthesia for Cesarean Section

  42. Maxeran 10 mg IV Clear antacid po IV expansion with RL or NS (15-20 mL/kg) Application of monitors Supplemental oxygen Epidural catheter at L2-3 or L3-4 LUD Test dose Therapeutic dose 5 ml boluses of 2% lido with epi 5ml boluses of 0.5% bupivacaine, 0.5% ropivacaine, or 3% 2-chloroprocaine (lidocaine or 2-chloroprocaine q 1-2 mins, bupiv or ropiv q 2-5 mins) Aggressive tx of hypotension Epidural Anesthesia for C-Section

  43. Drugs Used for Epidural Anesthesia for Cesarean Section

  44. Aids with Regional • 40-50% N2O • Low-dose ketamine (0.25 mg/kg) • Fentanyl 50-100 ug IV • Remifentanil • Metoclopramide, ondansetron, or droperidol may be given to treat nausea • Small dose of a benzodiazepine to treat anxiety and/or restlessness

  45. Local Anesthetic? • Int. J Ob Anesth. 2006; 15: 106-114. • Prospective, single blind study • Compared plain 0.5% bupivacaine (20 mL) with 2% lidocaine (20 mL) + 100 ug epi + 100 ug fentanyl for extending previous low-dose epidural analgesia for emergency c-sxn in 68 pts

  46. Local Anesthetic? • Sig. longer prep time for mixture (3.0 vs. 1.25 min) • Median onset time for block to T7 was 13.8 min for mixture and 17.5 min for plain bupivacaine • Difference not statistically different, and was offset by the longer prep time • Need for other intra-op supplementation was not significantly different between the groups • Lidocaine is cheaper and less toxic than alternatives

  47. Local Dose – How Low Can We Go? • Int J Ob Anesth, 2006; 15: 273-278. • Randomized to receive either intrathecal hyperbaric bupivacaine 3.75 mg or 9 mg, plus 25 ug fentanyl, 100 ug morphine, and 1.5% lidocaine epidurally 3 mL • Max sensory block achieved in low-dose group was significantly lower than that in conventional group (T4 vs. T2) • Longer time to reach maximum sensory level in low dose group (8.6 min vs. 6.8 min)

  48. Local Dose – How Low Can We Go? • Low-dose group had less motor block, faster sensory regression to T10 and faster motor recovery • No significant difference in need for epidural supplementation before or after delivery of baby • Low-dose group – less hypotension (14% vs. 73%) with less ephedrine usage

More Related